← Back to Discover
Ally Bridge Group (NY) LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $113,071,435
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- DEFINIUM THERAPEUTICS INC · COM SHS · 24477V105 · shares · CALL: $18,816,000
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares · CALL: $16,657,500
- MINERVA NEUROSCIENCES INC · COM NEW · 603380205 · shares: $12,075,701
- PROMIS NEUROSCIENCES INC · COM SHS · 74346M505 · shares: $8,163,398
- FIRST TRACKS BIOTHERAPEUTICS · ORD SHS · 337185102 · shares: $5,719,854
- AXSOME THERAPEUTICS INC · COM · 05464T104 · shares: $4,036,992
- ASSEMBLY BIOSCIENCES INC · COM NEW · 045396207 · shares: $3,847,200
- WHITEHAWK THERAPEUTICS INC · COM · 00032Q104 · shares: $3,746,161
- EDGEWISE THERAPEUTICS INC · COM · 28036F105 · shares: $3,384,479
- CLIMB BIO INC · COM · 28658R106 · shares: $3,249,203
Reported holdings
25 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | CALL | 400,000 shares | $18,816,000 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | CALL | 125,000 shares | $16,657,500 |
| MINERVA NEUROSCIENCES INC | COM NEW | 603380205 | — | 2,175,802 shares | $12,075,701 |
| PROMIS NEUROSCIENCES INC | COM SHS | 74346M505 | — | 620,319 shares | $8,163,398 |
| FIRST TRACKS BIOTHERAPEUTICS | ORD SHS | 337185102 | — | 284,287 shares | $5,719,854 |
| AXSOME THERAPEUTICS INC | COM | 05464T104 | — | 16,493 shares | $4,036,992 |
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | — | 140,000 shares | $3,847,200 |
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | — | 817,939 shares | $3,746,161 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 83,300 shares | $3,384,479 |
| CLIMB BIO INC | COM | 28658R106 | — | 249,172 shares | $3,249,203 |
| KURA ONCOLOGY INC | COM | 50127T109 | — | 290,000 shares | $3,181,300 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 775,000 shares | $2,906,250 |
| AVALO THERAPEUTICS INC | SPONSORED ADS | 05338F306 | — | 150,000 shares | $2,772,000 |
| PALISADE BIO INC | COM | 696389402 | — | 1,229,000 shares | $2,568,610 |
| SOLID BIOSCIENCES INC | COM | 83422E204 | — | 255,959 shares | $2,557,030 |
| AN2 THERAPEUTICS INC | COM | 037326105 | — | 526,315 shares | $2,547,365 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 69,183 shares | $2,545,934 |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | — | 743,958 shares | $2,536,897 |
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | — | 67,500 shares | $2,515,725 |
| INVENTIVA SA | ADS | 46124U107 | — | 634,800 shares | $2,399,544 |
| ALUMIS INC | COM | 022307102 | — | 76,459 shares | $2,151,556 |
| OVID THERAPEUTICS INC | COM | 690469101 | — | 624,561 shares | $1,680,069 |
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | — | 252,175 shares | $1,666,877 |
| IBIO INC | COM NEW | 451033708 | — | 390,147 shares | $682,757 |
| TRAWS PHARMA INC | COM | 68232V884 | — | 786,236 shares | $663,033 |